Applied BioCode, Inc.

Applied BioCode is an in-vitro diagnostics (IVD) manufacturer specializing in cost-effective, high-throughput syndromic panel testing for infectious diseases. The company designs and commercializes multiplex molecular diagnostic systems and assays that enable clinical and research laboratories to detect multiple pathogens simultaneously. The flagship BioCode® MDx-3000 platform processes up to 188 patient samples per 8-hour shift using 96-well format automation and can run up to three different syndromic panels in parallel. Core technology includes barcoded magnetic beads for multiplex PCR amplification, hybridization, target capture, and detection. Products address respiratory infections, gastrointestinal pathogens, SARS-CoV-2, sexually transmitted infections, and fungal pathogens. The platform offers data-masking capabilities to optimize insurance reimbursement and streamline laboratory workflows by eliminating the need for multiple instruments.